Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $157,624 - $189,123
-1,650 Reduced 28.13%
4,216 $408,000
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $60,468 - $67,374
-600 Reduced 9.28%
5,866 $640,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $114,072 - $133,824
1,200 Added 22.79%
6,466 $710,000
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $101,598 - $117,631
1,050 Added 24.91%
5,266 $510,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $171,030 - $208,560
1,500 Added 55.23%
4,216 $499,000
Q4 2021

Jan 31, 2022

BUY
$115.53 - $141.46 $29,460 - $36,072
255 Added 10.36%
2,716 $382,000
Q1 2020

Apr 30, 2020

SELL
$62.82 - $91.86 $4,020 - $5,879
-64 Reduced 2.53%
2,461 $194,000
Q4 2018

May 21, 2019

BUY
$65.56 - $74.27 $165,539 - $187,531
2,525 New
2,525 $183,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bessemer Securities LLC Portfolio

Follow Bessemer Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Securities LLC with notifications on news.